期刊文献+

质粒pcDNA3.1-IL-24的制备和纯化

Preparation and purification of plasmid pcDNA3.1-IL-24
下载PDF
导出
摘要 探索基因治疗用质粒pcDNA3.1-IL-24的规模化制备和纯化工艺。碱性裂解提取质粒后,以异丙醇和LiCl沉淀法去除大分子RNA。然后,使用DEAE Sepharose FF离子交换层析去除染色体DNA、小分子RNA、蛋白质等杂质。经本工艺纯化的质粒pcDNA3.1-IL-24浓度为727μg/mL,纯度为1.87,蛋白质含量为0.007μg/mL质粒DNA,未检测到RNA、抗生素残留。此工艺避免使用动物源性酶类及有毒试剂,有效去除质粒DNA制备过程中产生的杂质,可实现药剂水平质粒DNA的规模制备。 Large-scale preparation and purification of plasmid pcDNA3.1-IL-24 for gene therapy are explored in the paper.In the extracted plasmid with alkaline lysis method,the macromolecular RNA is removed,and then some other impurities like chromosomal DNA,micromolecular RNA and protein are get rid of with Sepharose FF ion exchange chromatography.The concentration,purity and protein content of the purified plasmid pcDNA3.1-IL-24 are 727 μg/mL,1.87 and 0.007 μg/mL plasmid DNA respectively.No any RNA or antibiotic are detected.The process avoids any animal-derived enzymes or toxic solvent to remove the impurities from plasmid DNA and can realize the large-scale preparation and purification of therapeutic-grade plasmid DNA.
出处 《长春工业大学学报》 CAS 2010年第1期81-84,共4页 Journal of Changchun University of Technology
基金 吉林省教育厅基金资助项目(2008109)
关键词 pcDNA3.1-IL-24 纯化 质量检测 pcDNA3.1-IL-24 purification quality inspection.
  • 相关文献

参考文献10

  • 1Fisher PB.Is mda-7/IL-24 a"Magic Bullet" for cancer[J].Cancer Res.,2005,65(22):10128-10138.
  • 2Su Z Z,Lebedeva I V,Sarkar D,et al.Ionizing radiation enhances therapeutic activity of mda-7/IL-24:overcoming radiation-and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2[J].Oncogene,2006,25:2339-2348.
  • 3Madireddi M T,Su Z Z,Young C S,et al.Mda-7,a novel melanoma differentiation associated gene with promise for cancer gene therapy[J].Adv.Exp.Med.Biol.,2000,465:239-261.
  • 4Saito Y,Miyahara R,Gopalan B,et al.Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated-7 (mda-7)/interleukin-24 (IL-24) gene[J].Cancer.Gene.Ther.,2005,12:238-247.
  • 5Tan P H,Chan C L,George A J.Strategies to improve non-viral vectors-potential applications in clinical transplantation[J].Expert.Opin.Biol.Ther.,2006,6(6):619-630.
  • 6刘永哲,吴丛梅,倪冠英,金顺子.IL-24基因联合电离辐射对前列腺癌PC-3细胞凋亡的影响[J].吉林大学学报(医学版),2008,34(2):171-174. 被引量:3
  • 7李霄,金宁一,米志强,连海,孙迎春,李杰,管国芳.联合应用凋亡素基因、新城疫病毒HN基因及IL-18基因对黑色素瘤的抑制效应研究[J].高技术通讯,2004,14(12):33-36. 被引量:8
  • 8萨姆布鲁克 J,弗里奇 E F,曼尼阿蒂斯 T.分子克隆实验指南[M].2版.金冬雁,黎孟枫,译.北京:科学出版社,1992.
  • 9蒋国润,周东霞,孙明,王玺,戴青,黄小琴,褚嘉祐.层析技术纯化核酸疫苗[J].中国生物制品学杂志,2007,20(2):129-132. 被引量:3
  • 10皮文辉,孙从建,宋志强,马连营,刘淑萍,白丁平,蔡宜东,刘守仁.质粒DNA的阴离子交换色谱法纯化及内毒素去除[J].色谱,2007,25(6):809-813. 被引量:11

二级参考文献34

  • 1高守红,范国荣,吴玉田.浊点萃取法在生物医药中的应用[J].中国医药工业杂志,2005,36(7):428-433. 被引量:9
  • 2萨姆布鲁克J 拉塞尔DW 黄培堂 王嘉玺 朱厚础 译.分子克隆实验指南(第3版)[M].北京:科学出版社,2002.2-140.
  • 3Zeng J, Fournier P, Schirrmacher V. Stimulation of human natural interferon-alpha response via paramyxovirus hemagglutinin lectin-cell interaction.Mol Med,2002,80(7):443
  • 4Pietersen A M, Rutjes S A, Van Tongeren J, et al.The tumor-selective viral protein apoptin effectively kills human biliary tract cancer cells.Mol Med,2003, 28
  • 5Xia D, Zheng S, Zhang W,et al.Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen. Mol Med,2003,81(9):585
  • 6Schirrmacher V,Ahlert T,Probstle T et al.Immunization with virus-modified tumor cells.Semin Oncol,1998,25(6):177
  • 7Zeng J, Fournier P, Schirrmacher V. Induction of interferon-alpha and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus.Virology,2002,297(1)
  • 8Takaoka A, Hayakawa S, Yanai H, et al. Integration of interferon-α/β signaling to p53 responses in tumour suppression and antiviral defence.Nature,2003,424:516
  • 9Pietersen A,Noteborn H M,Apoptin.Med Biol,2000,465
  • 10Segel M J, Izbicki G, Cohen P Y,et al.Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis.Physiol Lung Cell Mol Physiol,2003,285(6):L1255

共引文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部